JS
Therapeutic Areas
Axolotl Biologix Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Axolotl Graft Portfolio Clinical Validation | Wound Healing / Tissue Repair | Post-Market Study |
Leadership Team at Axolotl Biologix
AT
Aaron Tabor
Chief Science Officer
TA
Tim Allen
Chief Operations Officer
AI
Alison Ingraldi
Sr. Research Manager